Health ❯Healthcare ❯Obesity ❯Treatment Options

GLP-1 Agonists

UK Regulator Probes Pancreatitis Cases Linked to GLP-1 Weight-Loss Drugs

MHRA’s new study will analyse patient DNA to identify genetic risk factors following reports of drug-linked pancreatitis deaths.

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

UK Government Trials Weight-Loss Jabs to Tackle Unemployment